Intelligent Disulfide Bond Analysis
|
|
- Asher Hunter
- 6 years ago
- Views:
Transcription
1 Intelligent Disulfide Bond Analysis
2 Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition Protect IP by making biotherapeutics harder to copy
3 Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition Protect IP by making biotherapeutics harder to copy
4 Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition Protect IP by making biotherapeutics harder to copy
5 Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition Protect IP by making biotherapeutics harder to copy
6 Regulatory Guidelines HIGHER ORDER STRUCTURE IS CRITICAL!
7 Regulators Are Asking. Higher Order Structure is specifically mentioned in USFDA, EMEA and ICH guidelines
8 Newer Guidelines ADDED Demand for Analysis of Biotherapeutics USA BPCI act of 2009 established a framework and in 2012 the USFDA guidelines for biosimilars: a totality of the evidence approach, by evaluating more attributes and combinations of attributes at greater sensitivities with multiple complementary methods. the scope and extent of [clinical] studies may be reduced further if more extensive fingerprint-like characterization is used.
9 FDA desire for specific innovations in biotherapeutic analysis Steven Kozlowski, M.D. Director, Office of Biotechnology Products Office of Pharmaceutical Science Center for Drug Evaluation and Research Food and Drug Administration Three Specific Properties Needing Improved Measurement [The] FDA has identified three properties of therapeutic proteins that cannot be sufficiently measured at this time but that are very important for understanding the behavior of protein drugs Post-translation Modifications 2. Three-dimensional Structure 3. Protein Aggregation TESTIMONY BEFORE THE SUBCOMMITTEE ON TECHNOLOGY AND INNOVATION COMMITTEE ON SCIENCE AND TECHNOLOGY. U.S. HOUSE OF REPRESENTATIVES. SEPTEMBER 24, 2009
10 FDA desire for specific innovations in Biotherapeutic analysis Steven Kozlowski, M.D. Director, Office of Biotechnology Products Office of Pharmaceutical Science Center for Drug Evaluation and Research Food and Drug Administration Three Specific Properties Needing Improved Measurement [The] FDA has identified three properties of therapeutic proteins that cannot be sufficiently measured at this time but that are very important for understanding the behavior of protein drugs Post-translation Modifications 2. Three-dimensional Structure 3. Protein Aggregation TESTIMONY BEFORE THE SUBCOMMITTEE ON TECHNOLOGY AND INNOVATION COMMITTEE ON SCIENCE AND TECHNOLOGY. U.S. HOUSE OF REPRESENTATIVES. SEPTEMBER 24, 2009
11 Protein Metrics Higher Order Structure
12 Higher Order Structure Covered in Multiple Ways Disulfide Bonds (Secondary Structure) Higher Order Structure Epitope Mapping (Oxidative Footprinting) Cross-Linking Studies Ask for our posters at:
13 Why are Disulfide Bonds so Hard to Study? Maths VERY Large search space Variability Sample Issues Batch-to-batch changes Sample prep/ handling Protein Variation Family of molecules Dynamic system Mass Spec issues Ionization Fragmentation LC and CE challenges DIFFICULT! Size
14 Why are Disulfide Bonds so Hard to Study? Maths VERY Large search space Variability Sample Issues Batch-to-batch changes Sample prep/ handling Protein Variation Family of molecules Dynamic system Mass Spec issues Ionization Fragmentation LC and CE challenges DIFFICULT! Size
15 Why are Disulfide Bonds so Hard to Study? Maths VERY Large search space Variability Sample Issues Batch-to-batch changes Sample prep/ handling Protein Variation Family of molecules Dynamic system Mass Spec issues Ionization Fragmentation LC and CE challenges DIFFICULT! Size
16 Why are Disulfide Bonds so Hard to Study? Maths VERY Large search space Variability Sample Issues Batch-to-batch changes Sample prep/ handling Protein Variation Family of molecules Dynamic system Mass Spec issues Ionization Fragmentation LC and CE challenges DIFFICULT! Size
17 How do I Simplify Disulfide Bond Analysis?
18 Workflow Automation Disulfide Bond Identification and Presentation FIND the Bonds Divide between Expected and Shuffled Report
19 Byonic: Added Scoring Regime Score fragments of PeptideA AND PeptideX AND fragments of PeptideA+PeptideX Provide a combined X-Link Score PEPTIDEABCDEF PEPTIDECXYZ
20 Dedicated Byonic Tab Crosslinking and Disulfide Bonds Simple check box for users Same process as for cross-linked proteins
21 Dedicated Byonic Tab Crosslinking and Disulfide Bonds Links BETWEEN and INTRA-chain can be controlled e.g. Chain 1 links to Chain 2
22 Dedicated Byonic Tab Crosslinking and Disulfide Bonds Links BETWEEN and INTRA-chain can be controlled e.g. Chain 1 links to Chain 2 Use ; means 1 and 2 DO NOT LINK TO CHAIN 3 Intra-chain bonds only Chain1 Chain2 Chain3xxxxxCx
23 Dedicated Byonic Tab Crosslinking and Disulfide Bonds All theoretical bonds can be searched Generate Details button displays which bonds will be searched
24 SORT the Bonds in Byologic - Automated IgG Function Dedicated Disulfides Tab in Byologic allows user to select IgG function
25 SORT the Bonds in Byologic - Automated IgG Function Bonds are automatically assigned for IgG molecules All these bonds are EXPECTED
26 SORT the Bonds in Byologic - Automated IgG Function Table is editable! User can select specific bond locations Useful for Engineered IgGs/ ADCs/ multispecifics etc.
27 SORT the Bonds in Byologic - List for User Review Bonds are sorted into categories: all bonds in the table are Expected All other bonds are Shuffled
28 REPORT the Bonds in Byologic - Automated Graphing Protein Metrics has provided a pre-set report for Disulfide Bonds
29 Byologic Report Automated Graphs Report tables and graphs are generated at the click of a button Data in the report reflects what is in the project
30 Poster Presented at ASMS XIC for quantitation Unambiguous identification of disulfide and trisulfide bonds Copy available on request from
31 Ask us for the Technical Note on Performing Disulfide Bond Analysis Comprehensive overview of the use of Byonic and Byologic for Disulfide Bonds For a copy contact us at /resources
32 Protein Metrics Product Promise Byonic Protein and Peptide ID Intact Mass Sample ID and Comparison Byomap Chromatogram Analysis Quality of Results Intuitive User Experience Vendor Neutral Solutions Supernovo mab de novo sequencing Byologic Inspection, Quant, Reporting Workflow Automation Cost & Time Savings
33 Pfizer Sequence Variant Webinar Old way was slow, inefficient, manual Pfizer needs to monitor all sequence variants as part of development All potential sequence variants need to be accurately assessed and quantified Protein Metrics Byonic and Byologic tools provide an ideal workflow Ability to dig very deep into the data and AUTOMATE the analysis New way with Protein Metrics is fast, efficient and automated - and MORE SAMPLES can be analyzed.
34 ADC webinar StemCentrx (BRK and PMI) Ability to use ALL of the data, no matter how complex Bruker data on Antibody-Drug-Conjugates (ADCs) in a StemCentrx webinar shows complex data Need to calculate Drug-to-Antibody Ratio (DAR) StemCentrx, Bruker and Protein Metrics worked to improve the workflow in a real-world environment with HIGHLY COMPLEX data
35 Bi-Specific webinar with Genentech Moving data processing to the next level of efficiency Software to quickly identify and report desired, undesired and unknown species High throughput capabilities
36 Thank You For a live demo contact info@proteinmetrics.com
Byos. A Clear Sky Solution for Analytical Scientists
A Clear Sky Solution for Analytical Scientists One-touch Platform to Launch Seamless Workflows Raw File Report in Minutes Integrated application with templated workflows Workflows Step 1: Click to launch
More informationVendor Neutral Host Cell Protein Analysis
Vendor Neutral Host Cell Protein Analysis Regulator Positions on HCPs VERY CLEAR Regulators classify residual host cell proteins (HCPs) as process-related impurities [ICH Q6B, Q2B]. Finding, measuring
More informationBioConfirm B Presentation
BioConfirm B.08.00 Presentation 1 Major Enhancements to Increase Your Productivity The Latest Version of our BioConfirm Product, B.08.00 BioConfirm is protein and peptide characterization software using
More informationMass Spectrometry for Characterization of Monoclonal Antibodies: Regulatory Considerations
Mass Spectrometry for Characterization of Monoclonal Antibodies: Regulatory Considerations Jun Park, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products OPS/CDER Food and Drug Administration
More informationRapidly Characterize Antibody- Drug Conjugates and Derive Drug-to-Antibody Ratios Using LC/MS
Rapidly Characterize Antibody- Drug Conjugates and Derive Drug-to-Antibody Ratios Using LC/MS Ning Tang, Ph.D. Agilent Technologies Santa Clara, California, USA Heterogeneity in ADCs Complexity T-DM1 (Genentech)
More informationAgilent MassHunter BioConfirm Software NEW FRONTIERS IN THE CHARACTERIZATION OF BIOMOLECULES
Agilent MassHunter BioConfirm oftware NEW FRONTIER IN THE CHARACTERIZATION OF BIOMOLECULE NEW WORKFLOW FOR INTACT PROTEIN AND PROTEIN DIGET Biopharmaceutical discovery and development labs demand speed
More informationAnswers, Simple and Streamlined. Solutions for Biotherapeutic Intact Mass Analysis
Answers, Simple and Streamlined Solutions for Biotherapeutic Intact Mass Analysis Expert Functionality for Mass Spec Non-Experts SCIEX OS on the X500B QTOF system dramatically improves the user experience,
More informationIMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY
IMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY Research, development and production of biopharmaceuticals is growing rapidly, thanks to the increase of novel therapeutics and biosimilar
More informationThermo Scientific MAbPac HIC Columns. Novel Hydrophobic Interaction HPLC Columns. Designed for Monoclonal Antibody Analysis
Thermo Scientific MAbPac HIC Columns Novel Hydrophobic Interaction HPLC Columns Designed for Monoclonal Antibody Analysis Introduction The Thermo Scientific MAbPac HIC column family is designed for separations
More informationStreamlined and Complete LC-MS Workflow for MAM
Streamlined and Complete LC-MS Workflow for MAM Multiple Attribute Methodology (MAM) for Biotherapeutic Attribute Monitoring and Purity Testing BV MAM WORKFLOW Define Track Quantify Purity New Peaks Report
More informationAntibody-Drug Conjugate Characterization and Quality Assurance
Antibody-Drug Conjugate Characterization and Quality Assurance Sarah Kennett Division of Monoclonal Antibodies Office of Biotechnology Products OPS/CDER/FDA October 12, 2011 1 Disclaimer The views and
More informationProteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1
Routine Characterization of mabs and Other Proteins Patrick Boyce Biopharmaceutical Marketing Manager Europe and India 2011 Waters Corporation 1 Agenda Why? What scientific challenges? Technology Example
More informationEnsure your Success with Agilent s Biopharma Workflows
Ensure your Success with Agilent s Biopharma Workflows Steve Madden Software Product Manager Agilent Technologies, Inc. June 5, 2018 Agenda Agilent BioPharma Workflow Platform for LC/MS Intact Proteins
More informationApplication Note. Abstract. Author. Biopharmaceutical
Innovator and Biosimilar Monoclonal Antibody-Peptide Map Comparison Using the Agilent 70 Capillary Electrophoresis System and Agilent MatchCompare Software Application Note Biopharmaceutical Author Arunkumar
More information3D Structure of Biologics in a Convenient Immunoassay Format
3D Structure of Biologics in a Convenient Immunoassay Format Xing Wang, Ph.D. Array Bridge Inc. 5/25/2017 1 Topics Covered Today Why New Technologies? Technology Development. Case Studies for Novel and
More informationPrecise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF
Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF Application Note Author David L. Wong Agilent Technologies, Inc. Santa Clara, CA, USA Introduction Monoclonal
More informationSimple, Robust, High Quality Intact Mass Analysis A Biosimilars Case Study
3 Conjugation Site (ADC) 4 34 35 1 1 35 34 CASE STUDY 3 National Institute for Bioprocessing 3 4 Research and Training 1 35 31 5 31 3 6 9 3 9 5 6 7 7 6 8 8 3 1 19 16 17 19 18 7 9 11 11 5 17 9 7 3 1 9 9
More informationBiochromatography Bring more Zen into your life and laboratory
Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might
More informationComprehensive characterization of three IgG forms using CESI-MS
Comprehensive characterization of three IgG forms using CESI-MS Bryan Fonslow 1, Olga V. Friese 2, and K. Steven Cook 2 1 SCIEX, Brea, CA and 2 Pfizer, Chesterfield, MO mabs, ADCs, biosimilars, and biobetters
More informationEnabling routine characterization of proteins. Agilent MassHunter BioConfirm software
Enabling routine characterization of proteins Agilent MassHunter BioConfirm software Bioconfirm a key component of your major biopharma workflows Intact protein analysis BioConfirm will rapidly deconvolute
More informationrapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF
rapiflex Designed for Molecules that Matter. Innovation with Integrity MALDI TOF/TOF rapiflex TM The first MALDI-TOF/TOF that adapts to your needs. The rapiflex is the most advanced MALDI TOF/TOF system
More informationHost Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF
Application Note Biotherapeutics and Biosimilars Host Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF Authors Linfeng Wu, Shuai Wu and Te-Wei Chu Agilent Technologies,
More informationThe Ludger GX-mAb Glycoprofiling Service High Throughput glycan analysis service of monoclonal antibodies (mabs) for drug developers and manufacturers
The Ludger GX-mAb Glycoprofiling Service High Throughput glycan analysis service of monoclonal antibodies (mabs) for drug developers and manufacturers Dr Richard Gardner Senior Chemist richard.gardner@ludger.com
More informationRegulatory Perspectives on Higher Order Structure Evaluations for Protein Products. Emily Shacter, Ph.D.
Regulatory Perspectives on Higher Order Structure Evaluations for Protein Products Emily Shacter, Ph.D. Chief, Laboratory of Biochemistry U.S. Food and Drug Administration Center for Drug Evaluation and
More informationChromatography column for therapeutic protein analysis
PRODUCT SPECIFICATIONS ProPac Elite WCX Column Chromatography column for therapeutic protein analysis Benefits Superior resolution power for proteins, monoclonal antibodies, and associated charge variants
More informationApplication Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins
Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins BioPharma Compass TM is a fully automated solution for the rapid characterization
More informationHighly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs
Technical Overview Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Authors Stephen Madden, Crystal Cody, and Jungkap Park Agilent Technologies, Inc. Santa Clara, California,
More informationautoflex max Practical Power, Maximum Utility Innovation with Integrity MALDI-TOF MS
autoflex max Practical Power, Maximum Utility Innovation with Integrity MALDI-TOF MS Wide application versatility with enhanced dynamic range The autoflex max series is based on Bruker s robust and efficient
More informationAntibody-drug Conjugates: Characterization and Control Strategies of Lysine-linked Products
Antibody-drug Conjugates: Characterization and Control Strategies of Lysine-linked Products Fred Jacobson Protein Analytical Chemistry Genentech, Inc. CASSS CMC Strategy Forum Japan 2013 December 9-10,
More informationUtilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination
Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination Kelli Jonakin, Ph.D. Senior Field Application Scientist, Seattle, WA Eric Johansen, Ph.D. Senior
More informationThe Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives
The Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives Jun Park, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products CDER/FDA CASSS, Applications of
More informationThermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development
Thermo Scientific Solutions for Intact-Protein Analysis Better, Faster Decisions for Biotherapeutic Development Quickly and Accurately Assess Product Quality and Safety Therapeutic proteins and monoclonal
More informationRapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution
Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution Rapidly Identify Major Catabolites with the SCIEX X500R QTOF System and MetabolitePilot TM 2.0 Software Ian Moore and Jinal Patel
More informationThermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.
Thermo Scientific Peptide Mapping Workflows Upgrade Your Maps Fast, confident and more reliable peptide mapping. Smarter Navigation... Peptide mapping is a core analytic in biotherapeutic development.
More informationAnalytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars
Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Jared Auclair, Ph.D. Northeastern University Department of Chemistry and Chemical Biology Barnett Institute of Chemical
More informationProfiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF
Application Note Biotherapeutics and Biosimilars Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 64XT AdvanceBio LC/Q TOF Author David L. Wong Agilent Technologies, Inc.
More informationPut the PRO in Protein Characterization
Put the PRO in Protein Characterization Aaron Boice LC/Q-TOF Product Manager 5-June-2017 Agenda The Right Tools for the Job Tackling Intact Proteins Break it Down Peptides and PTMs Sweet Success Released
More informationAssistant Professor Mohammad A Alsenaidy, MSc, PhD, Saudi Arabia
GaBI Scientific Meetings First GCC Stakeholder Meeting on Approval Process, Interchangeability/Substitution and Safety of Biosimilars 20 November 2017, Holiday Inn Izdihar Riyadh, Saudi Arabia Assistant
More informationThe United States Pharmacopeia Strategy on Biotherapeutic Products Standards. Jaap Venema, Ph.D. Chief Science Officer & Chair, Council of Experts
The United States Pharmacopeia Strategy on Biotherapeutic Products Standards Jaap Venema, Ph.D. Chief Science Officer & Chair, Council of Experts U.S. Pharmacopeia Who We Are Scientific, independent, volunteer-driven,
More informationTony Mire-Sluis Vice President, Corporate, Product and Device Quality Amgen Inc
The Regulatory Implications of the ever increasing power of Mass Spectrometry and its role in the Analysis of Biotechnology Products Where do we draw the line? Tony Mire-Sluis Vice President, Corporate,
More informationIMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS
IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS As scientists gain an advanced understanding of diseases at the molecular level, the biopharmaceutical industry
More informationProMass HR Applications!
ProMass HR Applications! ProMass HR Features Ø ProMass HR includes features for high resolution data processing. Ø ProMass HR includes the standard ProMass deconvolution algorithm as well as the full Positive
More informationAdvanced QA/QC characterization MS in QC : Multi Attribute Method
Advanced QA/QC characterization MS in QC : Multi Attribute Method Global BioPharma Summit The world leader in serving science A Complex Problem: Drug Safety and Quality Safety Is the product safe to use?
More informationImproving Productivity with Applied Biosystems GPS Explorer
Product Bulletin TOF MS Improving Productivity with Applied Biosystems GPS Explorer Software Purpose GPS Explorer Software is the application layer software for the Applied Biosystems 4700 Proteomics Discovery
More informationLC/MS Based Quantitation of Intact Proteins for Bioanalytical Applications
LC/MS Based Quantitation of Intact Proteins for Bioanalytical Applications Alex Zhu, Ph.D. Agilent Technologies Wilmington, DE ASMS,2017-06 1 Outline Introduction on intact protein quantitation Agilent
More informationXpress CF+ : A Cell-Free Platform for the Rapid Screening and Production of Homogeneous ADCs
Xpress CF+ : A Cell-Free Platform for the Rapid Screening and Production of Homogeneous ADCs Alexander R. Steiner, M.S. Director, Protein Biochemistry Tuesday Feb 3 rd, 215 Making novel drugs is Pammolli
More informationGentle Bioanalysis of Proteins
Gentle Bioanalysis of Proteins APPLICA 2017 Patrick Endres, Judith Vajda, Egbert Müller GmbH September 7 th, 2017 Demand on chromatographic analysis Fast Inexpensive (Column and buffer) Robust (Easy method
More informationPrioritizing and Managing Key CMC Elements
Prioritizing and Managing Key CMC Elements Using 21 st Century Principles during Early Development Laurie Graham Product Quality/CMC Reviewer FDA/CDER/OPS/OBP Division of Monoclonal Antibodies 1 Disclaimer
More informationA Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics
A Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics Catalin Doneanu,, Ph.D. Biopharmaceutical Sciences, Waters September 16, 2009 Mass Spec 2009 2009 Waters Corporation Host Cell Proteins
More informationExpectations for Analytical Characterisation in the Evaluation of Biosimilarity: A Regulator`s Perspective
Expectations for Analytical Characterisation in the Evaluation of Biosimilarity: A Regulator`s Perspective Christian Mayer AGES - Austrian Agency for Health and Food Safety Analytical Technologies Europe
More informationMRMPilot Software: Accelerating MRM Assay Development for Targeted Quantitative Proteomics
Product Bulletin MRMPilot Software: Accelerating MRM Assay Development for Targeted Quantitative Proteomics With Unique QTRAP System Technology Overview Targeted peptide quantitation is a rapidly growing
More informationPeptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST
Peptide libraries: applications, design options and considerations Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Overview 1 2 3 4 5 Introduction Peptide library basics Peptide library design considerations
More informationZipChipTM. Microfluidic CE-ESI Chip Separations Biotherapeutics. March // Actionable Intelligence HPMS & On-board Analytics / Slide 1
ZipChipTM Microfluidic CE-ESI Chip Separations Biotherapeutics March 2016 // Actionable Intelligence HPMS & On-board Analytics / Slide 1 March 2016 //ZipChip Biotherapeutics Analysis Summary Fast, high-resolution
More informationAnalysis of Protein Biopharmaceuticals
Analysis of Protein Biopharmaceuticals Comprehensive cgmp Services at Every Stage of Drug Development Amazing where you can go At Solvias, we work closely with you Solvias provides comprehensive services
More informationMAbPac RP Column. High-performance reverse phase chromatography column for monoclonal antibody analysis
CHROMATOGRAPHY MAbPac RP Column High-performance reverse phase chromatography column for monoclonal antibody analysis Product Specifications The Thermo Scientific MAbPac RP is a reverse phase (RP) liquid
More informationMonoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct.
Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. 12, 211 Outline Orbitrap Mass Spectrometer in mab Characterization Intact
More informationThermo Scientific. MAbPac HIC-10. Product Manual. P/N: June Part of Thermo Fisher Scientific
Thermo Scientific MAbPac HIC-10 Product Manual P/N: June 2014 Part of Thermo Fisher Scientific Product Manual for MAbPac HIC-10 MAbPac HIC-10, 5 µm, 4.6 100 mm (P/N: 088480) MAbPac HIC-10, 5 µm, 4.6 250
More informationFDA Perspective: Recent Trends in the Regulation of Biopharmaceuticals
FDA Perspective: Recent Trends in the Regulation of Biopharmaceuticals CMC Strategy Forum LATAM 2014 Sarah Kennett, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products OPS,CDER, FDA
More informationSeparate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 126 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 3Å, 2.7 µm Column Application Note Biologics
More informationChromatographic Workflows for Biopharmaceutical Characterization
Chromatographic Workflows for Biopharmaceutical Characterization Dr. Ken Cook European Bioseparation Sales Support Expert Thermo Fisher Scientific, Hemel Hempstead/Germany The world leader in serving science
More informationDesign and Interpretation of Accelerated Stability Studies of Biologics
Design and Interpretation of Accelerated Stability Studies of Biologics Sheila G. Magil, Ph.D. Cambridge Healthtech Institute s Fourth Annual The Bioprocessing Summit 2012 August 20-23, 2012 Boston, MA
More informationHigher Order mab Aggregate Analysis using New Innovative SEC Technology
Higher Order mab Aggregate Analysis using New Innovative SEC Technology Ronald E. Majors, Ph.D. LCGC No. America West Chester, PA USA WCBP 2016 Washington, DC Linda Lloyd, Ph.D. Agilent Technologies Church
More informationProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation
ProteoGenix Life Sciences Services and Products From gene to biotherapeutics Target Validation to Lead optimisation ProteoGenix Philippe FUNFROCK, founder and CEO French company located in Strasbourg,
More informationA comprehensive CE/ESI-MS solution for BioPharma applications
A comprehensive CE/ESI-MS solution for BioPharma applications Thermo Scientific Q Exactive hybrid quadrupole-orbitrap mass spectrometers with ZipChip system Fast CE Separation Nanospray Sensitivity HRAM
More informationChallenges in peptide mapping mass spectrometry of biopharmaceuticals
Challenges in peptide mapping mass spectrometry of biopharmaceuticals Will Burkitt, Ben Holmes, Johanna Paris, Nisha Patel, John O Hara 07.MAR.2018 Characterisation within UCB 2 Context to the type of
More informationProPac Elite WCX, 5 μm Particle, for Fast, High Resolution Protein and mab Analysis. July 2018
ProPac Elite WCX, 5 μm Particle, for Fast, High Resolution Protein and mab Analysis July 218 ProPac Elite WCX Acidic Variants Basic Variants 5µm Weak Cation Exchange Column Chemistry based on Thermo Scientific
More informationBiosimilars Scientific Challenges and Implications
Biosimilars Scientific Challenges and Implications Professor Paul Declerck Laboratory for Therapeutic and Diagnostic Antibodies paul.declerck@pharm.kuleuven.be Biological medicinal product A well-defined
More informationDisulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column
Disulfide Linkage Analysis of IgG1 using an Agilent 126 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Application Note Biotherapeutics & Biosimilars Author M. Sundaram
More informationfaster, confident more path to all the information in your samples. Agilent MassHunter Workstation Software Our measure is your success.
Agilent MassHunter Workstation Software faster, A confident more path to all the information in your samples. Our measure is your success. products applications soft ware services MassHunter Workstation
More informationAPPLYING SCIENTIFIC CONSIDERATIONS AND STATISTICAL APPROACHES IN ANALYTICAL SIMILARITY ASSESSMENT
APPLYING SCIENTIFIC CONSIDERATIONS AND STATISTICAL APPROACHES IN ANALYTICAL SIMILARITY ASSESSMENT JENNIFER LIU CASSS CMC STRATEGY FORUM EUROPE 2017, MAY 22-24 BIOSIMILAR DEVELOPMENT BEGINS WITH THOROUGH
More informationRegulatory Consideration for the Characterization of HOS in Biotechnology Products
Regulatory Consideration for the Characterization of HOS in Biotechnology Products Maria Teresa Gutierrez Lugo, Ph.D. OBP/CDER/FDA 5 th International Symposium on Higher Order Structure of Protein Therapeutics
More informationHigh-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks
High-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks Mark Lies, Marcia Santos, and Tingting Li SCIEX Separations, Brea, CA Introduction Development of biopharmaceuticals
More informationThermo Scientific Ligand Binding Mass Spectrometric Immunoassay (LB-MSIA)
INSTRUCTIONS FOR USE OF PRODUCTS Thermo Scientific Ligand Binding Mass Spectrometric Immunoassay (LB-MSIA) Demonstration of the LB-MSIA Protocol for the Analysis of Intact Adalimumab from Mouse Plasma
More informationColumns for Biomolecules BioLC Column Lines
Columns for Biomolecules BioLC Column Lines Monoclonal Antibodies Glycans GlycanPac Nucleic Acids DNAPac Protein A Accucore Amide-HILIC DNAPac PA1 SEC-1 GlycanPac AXH-1 DNAPac PA2 SCX-1 GlycanPac AXR-1
More informationPfizer Informatics for NGS. Giles Day & Adam Kraut Pfizer BioTherapeutics R&D BioTeam, Inc. XGEN Mar 15 th 2010
Pfizer Informatics for NGS Giles Day & Adam Kraut Pfizer BioTherapeutics R&D BioTeam, Inc. XGEN Mar 15 th 2010 Rinat and Pfizer Small biotech purchased by Pfizer 2006 Located in South San Francisco Antibody
More informationRequirements for demonstrating biosimilarity of monoclonal antibodies
Requirements for demonstrating biosimilarity of monoclonal antibodies Dr. Steffen Gross Section Mono-/Polyclonal Antibodies Paul-Ehrlich-Institut Germany http://www.pei.de Outline Biosimilars Regulatory
More informationJohn Mehl, Bogdan Sleczka, Eugene Ciccimaro, Christian Caporuscio, Ekaterina Deyanova, Richard Huang, Timothy Olah, Celia D Arienzo
Bioanalytical strategies for the quantitation of in-vivo site specific modifications of therapeutic antibodies in early discovery cyno studies using IP-LC-MS John Mehl, Bogdan Sleczka, Eugene Ciccimaro,
More informationProteinPilot Software for Protein Identification and Expression Analysis
ProteinPilot Software for Protein Identification and Expression Analysis Providing expert results for non-experts and experts alike ProteinPilot Software Overview New ProteinPilot Software transforms protein
More informationWorkflows for the Characterization of Glycan structure on Biotherapeutics
New Innovations in UHPLC and LC-MS Workflows for the Characterization of Glycan structure on Biotherapeutics Ken Cook EU Bio-Separations Support Expert April 2015 1 The world leader in serving science
More informationRegulatory Updates for Biopharmaceutical Products:FDA Perspective
Regulatory Updates for Biopharmaceutical Products:FDA Perspective CMC Strategy Forum Europe 2016 Sarah Kennett Division of Biotechnology Review and Research I Office of Biotechnology Products OPQ,CDER,
More informationIncrease throughput: spend less time cutting and. any CDS into Agilent's ELN
Increase throughput: spend less time cutting and pasting. Smart Import your results directly from any CDS into Agilent's ELN e-seminar, November 18 th, 2009 Agenda Introduction on Agilent Software and
More informationDevelopment of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns
Development of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns Anne Blackwell Bio Columns Product Support Scientist Suresh Babu Senior Application
More informationBiotherapeutic Non-Reduced Peptide Mapping
Biotherapeutic Non-Reduced Peptide Mapping Routine non-reduced peptide mapping of biotherapeutics on the X500B QTOF System Method details for the routine non-reduced peptide mapping of a biotherapeutic
More informationANTIBODY DRUG CONJUGATES AND BISPECIFIC ANTIBODIES: SCIENTIFIC & REGULATORY CHALLENGES AND OPPORTUNITIES
ANTIBODY DRUG CONJUGATES AND BISPECIFIC ANTIBODIES: SCIENTIFIC & REGULATORY CHALLENGES AND OPPORTUNITIES Brian DiPaolo 08 June 2017 CASSS Midwest Discussion Group Agenda Introduction Antibody Drug Conjugates
More informationDetection and Quantitation of Residual Host Cell DNA
Detection and Quantitation of Residual Host Cell DNA White Paper Author: Phil Kuhlman, Biopharmaceutical Technical Specialist 1 Abstract All biological drug products are required to be characterised for
More informationAgilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS
Agilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS GET FAST, ACCURATE, REPRODUCIBLE RESULTS The Agilent AssayMAP platform is an easy to use yet flexible
More informationMasterView Software. Turn data into answers reliable data processing made easy ONE TOUCH PRODUCTIVITY
MasterView Software Turn data into answers reliable data processing made easy ONE TOUCH PRODUCTIVITY Mass spectrometers especially high-resolution, accurate mass instruments produce a significant amount
More informationENTREPRENEURIAL OPPORTUNITIES IN LIFE SCIENCE QUALITY & REGULATORY
BIOANALYTICAL SOLUTIONS FOR BIOTHERAPEUTICS AND SMALL MOLECULE THERAPEUTICS ENTREPRENEURIAL OPPORTUNITIES IN LIFE SCIENCE QUALITY & REGULATORY MARCH 15, 2017 AIT BIOSCIENCE, LLC BIOANALYSIS TO SUPPORT
More informationIsotopic Resolution of Chromatographically Separated IdeS Subunits Using the X500B QTOF System
Isotopic Resolution of Chromatographically Separated IdeS Subunits Using the X500B QTOF System Fan Zhang 2, Sean McCarthy 1 1 SCIEX, MA, USA, 2 SCIEX, CA USA Analysis of protein subunits using high resolution
More informationAnalysis of Monoclonal Antibody and Related Substances using a New Hydrophobic Interaction Chromatography (HIC) Column
Analysis of Monoclonal Antibody and Related Substances using a New Hydrophobic Interaction Chromatography (HIC) Column Julia Baek, 1 Robert van Ling, 2 Xiaodong Liu 1 1 Thermo Fisher Scientific, Sunnyvale,
More informationWhat do physicians expect from a new drug?
What do physicians expect from a new drug? New drug Novel activity Efficacy Safety Affordable cost Approval of new biologic drugs Is consistently increasing New Biotech Drug and Vaccine Approvals/ New
More informationmab Glycopeptide Profiling with V-Tag Adding reliable glycoprofiling to your peptide mapping workflow with ease and simplicity
mab Glycopeptide Profiling with V-Tag Adding reliable glycoprofiling to your peptide mapping workflow with ease and simplicity Who is the V-Tag Glycoprofiling Technology for? V = Velocity The Ludger V-Tag
More informationSasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll
Impact of Sequence Variants on the Higher-Order Structure (HOS) of Monoclonal Antibodies Using an Optimized HDX- MS Method with a Dual-Protease Co-Immobilized Column Format Sasidhar N. Nirudodhi, Lin Tzihsuan,
More informationFDA recommendations for comparability studies to support manufacturing changes. Joslyn Brunelle, PhD Office of Biotechnology Products OPQ/CDER/FDA
FDA recommendations for comparability studies to support manufacturing changes Joslyn Brunelle, PhD Office of Biotechnology Products OPQ/CDER/FDA The views and opinions expressed here should not be used
More informationPost translational Modifications of Biologics: Impact on clinical safety and efficacy
Post translational Modifications of Biologics: Impact on clinical safety and efficacy Narendra Chirmule, PhD Senior Vice President Head of R&D Biocon, Bangalore, India 1 Extensive post translational modifications
More information